A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension

A Multi-center, Randomized, Open-label, Active comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared with Losartan in Patients with Diabetic Nephropathy and Hypertension

Inclusion Criteria:

• Male of Female subjects aged ≥19 or <75
• Type II Diabetes Mellitus subjects who have been taken medicine
• Subjects who have voluntarily decided to participate in this clinical trial and Signed ICF

Exclusion Criteria:

• Subjects with Type I Diabetes Mellitus
• Subjects with Primary hyper-aldosteronism
• Subjects with a history of drug or alcohol abuse or suspected patient within 1 year as of the time of screening
• Pregnant women, lactating women, or subjects who do not agree to use appropriate contraception during the clinical trial period
• Subjects who received other clinical trial drugs within 28 days of screening visit
• Subjects who are unable to participate in this clinical trial at the discretion of the investigator.